These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38530984)

  • 1. Correction to: Prognostic significance of haemodynamic parameters in patients with cardiogenic shock.
    Eur Heart J Acute Cardiovasc Care; 2024 Mar; ():. PubMed ID: 38530984
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic implications of microcirculatory perfusion versus macrocirculatory perfusion in cardiogenic shock: a CULPRIT-SHOCK substudy.
    Wijntjens GW; Fengler K; Fuernau G; Jung C; den Uil C; Akin S; van de Hoef TP; Šerpytis R; Diletti R; Henriques JP; Šerpytis P; Thiele H; Piek JJ
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):108-119. PubMed ID: 31517505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].
    Fornaro G; Prando MD; Parodi F; Cordero G; Sansa M; Bongo AS; Campi A; Aralda D; Dellavesa P; Aina F; Lazzero M; Cernigliaro C
    G Ital Cardiol; 1996 Dec; 26(12):1385-99. PubMed ID: 9162668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency jet ventilation (HFJV) has no better haemodynamic tolerance than controlled mechanical ventilation (CMV) in cardiogenic shock.
    Crimi G; Conti G; Bufi M; Antonelli M; de Blasi RA; Mattia C; Romano R; Gasparetto A
    Intensive Care Med; 1988; 14(4):359-63. PubMed ID: 3403768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of non-invasive measurement of central blood pressure and arterial stiffness in shock.
    Markakis K; Pagonas N; Georgianou E; Zgoura P; Rohn BJ; Bertram S; Seidel M; Bettag S; Trappe HJ; Babel N; Westhoff TH; Seibert FS
    Eur J Clin Invest; 2021 Sep; 51(9):e13587. PubMed ID: 34022074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistently low cardiac output predicts high mortality in newborns with cardiogenic shock.
    Sabatino G; Ramenghi LA; Verrotti A; Gerboni S; Chiarelli F
    Panminerva Med; 1998 Mar; 40(1):28-32. PubMed ID: 9573750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors.
    Riccardi M; Pagnesi M; Chioncel O; Mebazaa A; Cotter G; Gustafsson F; Tomasoni D; Latronico N; Adamo M; Metra M
    Eur J Heart Fail; 2024 Feb; 26(2):411-431. PubMed ID: 38391010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of cardiac reserve in cardiogenic shock: implications for prognosis and management.
    Tan LB; Littler WA
    Br Heart J; 1990 Aug; 64(2):121-8. PubMed ID: 2393609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic efficacy of microaxial left ventricular assist device in cardiogenic shock: a systematic review and meta-analysis.
    van Dort DIM; Peij KRAH; Manintveld OC; Hoeks SE; Morshuis WJ; van Royen N; Ten Cate T; Geuzebroek GSC
    Neth Heart J; 2020 Apr; 28(4):179-189. PubMed ID: 31811556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.
    Unverzagt S; Buerke M; de Waha A; Haerting J; Pietzner D; Seyfarth M; Thiele H; Werdan K; Zeymer U; Prondzinsky R
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD007398. PubMed ID: 25812932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of patients with cardiac amyloidosis admitted to an intensive care unit for acute heart failure.
    d'Humières T; Fard D; Damy T; Roubille F; Galat A; Doan HL; Oliver L; Dubois-Randé JL; Squara P; Lim P; Ternacle J
    Arch Cardiovasc Dis; 2018 Oct; 111(10):582-590. PubMed ID: 29709420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate hypothermia for severe cardiogenic shock (COOL Shock Study I & II).
    Schmidt-Schweda S; Ohler A; Post H; Pieske B
    Resuscitation; 2013 Mar; 84(3):319-25. PubMed ID: 23044413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality in patients with cardiogenic shock treated with the Impella CP microaxial pump for isolated left ventricular failure.
    Sieweke JT; Berliner D; Tongers J; Napp LC; Flierl U; Zauner F; Bauersachs J; Schäfer A
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):138-148. PubMed ID: 29405734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the Impella 2.5 system alone, after and in combination with an intra-aortic balloon pump in patients with cardiogenic shock: case description and review of the literature.
    Cubeddu RJ; Lago R; Horvath SA; Vignola PA; O'Neill W; Palacios IF
    EuroIntervention; 2012 Apr; 7(12):1453-60. PubMed ID: 22522555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Artery Catheter Monitoring in Patients with Cardiogenic Shock: Time for a Reappraisal?
    Bertaina M; Galluzzo A; Morici N; Sacco A; Oliva F; Valente S; D'Ascenzo F; Frea S; Sbarra P; Petitti E; Prever SB; Boccuzzi G; Zanini P; Attisani M; Rametta F; De Ferrari GM; Noussan P; Iannaccone M
    Card Fail Rev; 2022 Jan; 8():e15. PubMed ID: 35541286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development.
    Lindholm MG; Køber L; Boesgaard S; Torp-Pedersen C; Aldershvile J;
    Eur Heart J; 2003 Feb; 24(3):258-65. PubMed ID: 12590903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group.
    Hands ME; Rutherford JD; Muller JE; Davies G; Stone PH; Parker C; Braunwald E
    J Am Coll Cardiol; 1989 Jul; 14(1):40-6; discussion 47-8. PubMed ID: 2738272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic findings in cardiogenic shock, risk prediction, and the effects of emergency revascularization: results from the SHOCK trial.
    White HD; Palmeri ST; Sleeper LA; French JK; Wong CK; Lowe AM; Crapo JW; Koller PT; Baran KW; Boland JL; Hochman JS; Wagner GS;
    Am Heart J; 2004 Nov; 148(5):810-7. PubMed ID: 15523311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impella CP use in patients with non-ischaemic cardiogenic shock.
    Maniuc O; Salinger T; Anders F; Müntze J; Liu D; Hu K; Ertl G; Frantz S; Nordbeck P
    ESC Heart Fail; 2019 Aug; 6(4):863-866. PubMed ID: 31095902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and outcome of peri-procedural cardiogenic shock: results from the international Euro Heart Survey PCI registry.
    Weipert KF; Bauer T; Nef HM; Hochadel M; Weidinger F; Gitt AK; Zeymer U; Hamm CW
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):120-127. PubMed ID: 30618264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.